Published in Neuropharmacology on March 01, 2005
Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol (2008) 21.53
NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease. Nat Rev Neurosci (2013) 4.35
MPX-004 and MPX-007: New Pharmacological Tools to Study the Physiology of NMDA Receptors Containing the GluN2A Subunit. PLoS One (2016) 1.45
Dieldrin exposure induces oxidative damage in the mouse nigrostriatal dopamine system. Exp Neurol (2007) 1.24
Maladaptive striatal plasticity in L-DOPA-induced dyskinesia. Prog Brain Res (2010) 1.23
Cell type-specific plasticity of striatal projection neurons in parkinsonism and L-DOPA-induced dyskinesia. Nat Commun (2014) 1.10
Effects of a NR2B selective NMDA glutamate antagonist, CP-101,606, on dyskinesia and Parkinsonism. Mov Disord (2008) 1.08
Evaluation of levodopa dose and magnitude of dopamine depletion as risk factors for levodopa-induced dyskinesia in a rat model of Parkinson's disease. J Pharmacol Exp Ther (2007) 1.05
Chronic NMDA administration increases neuroinflammatory markers in rat frontal cortex: cross-talk between excitotoxicity and neuroinflammation. Neurochem Res (2008) 1.00
Differences in excitatory transmission between thalamic and cortical afferents to single spiny efferent neurons of rat dorsal striatum. Eur J Neurosci (2008) 0.98
PSD-95 expression controls L-DOPA dyskinesia through dopamine D1 receptor trafficking. J Clin Invest (2012) 0.98
Amantadine for dyskinesias in Parkinson's disease: a randomized controlled trial. PLoS One (2010) 0.92
Potential future neuroprotective therapies for neurodegenerative disorders and stroke. Clin Geriatr Med (2010) 0.88
Striatal proteomic analysis suggests that first L-dopa dose equates to chronic exposure. PLoS One (2008) 0.87
Motor cortical plasticity in Parkinson's disease. Front Neurol (2013) 0.86
Dopamine receptor activation reveals a novel, kynurenate-sensitive component of striatal N-methyl-D-aspartate neurotoxicity. Neuroscience (2007) 0.85
Mathematical insights into the effects of levodopa. Front Integr Neurosci (2012) 0.83
Design, synthesis, and structure-activity relationship of a novel series of GluN2C-selective potentiators. J Med Chem (2014) 0.83
Drug-induced dyskinesia in Parkinson's disease. Should success in clinical management be a function of improvement of motor repertoire rather than amplitude of dyskinesia? BMC Med (2013) 0.82
Retracted Chronic NMDA administration to rats increases brain pro-apoptotic factors while decreasing anti-Apoptotic factors and causes cell death. BMC Neurosci (2009) 0.82
Levodopa-induced dyskinesias in Parkinson's disease: emerging treatments. Neuropsychiatr Dis Treat (2013) 0.82
GluN2A and GluN2B NMDA receptor subunits differentially modulate striatal output pathways and contribute to levodopa-induced abnormal involuntary movements in dyskinetic rats. ACS Chem Neurosci (2013) 0.81
Brain morphometry and the neurobiology of levodopa-induced dyskinesias: current knowledge and future potential for translational pre-clinical neuroimaging studies. Front Neurol (2014) 0.81
Therapeutic potential of targeting glutamate receptors in Parkinson's disease. J Neural Transm (Vienna) (2014) 0.78
Targeting β-arrestin2 in the treatment of L-DOPA-induced dyskinesia in Parkinson's disease. Proc Natl Acad Sci U S A (2015) 0.78
Discovery of 3-substituted aminocyclopentanes as potent and orally bioavailable NR2B subtype-selective NMDA antagonists. ACS Chem Neurosci (2011) 0.77
NMDA receptor GluN2A/GluN2B subunit ratio as synaptic trait of levodopa-induced dyskinesias: from experimental models to patients. Front Cell Neurosci (2015) 0.76
Exogenous Alpha-Synuclein Alters Pre- and Post-Synaptic Activity by Fragmenting Lipid Rafts. EBioMedicine (2016) 0.75
Effect of the metabotropic glutamate antagonist MPEP on striatal expression of the Homer family proteins in levodopa-treated hemiparkinsonian rats. Psychopharmacology (Berl) (2009) 0.75
Targeting the D1-N-methyl-d-aspartate receptor complex reduces l-dopa-induced dyskinesia in 6-hydroxydopamine-lesioned Parkinson's rats. Drug Des Devel Ther (2016) 0.75
Roles of Ca(2+)/calmodulin-dependent protein kinase II in subcellular expression of striatal N-methyl-D-aspartate receptors in l-3, 4-dihydroxyphenylalanine-induced dyskinetic rats. Drug Des Devel Ther (2015) 0.75
A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A (1998) 24.58
Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science (1998) 17.91
Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli. Proc Natl Acad Sci U S A (2002) 13.83
Negative feedback regulation of TGF-beta signaling by the SnoN oncoprotein. Science (1999) 7.51
Purification and biochemical heterogeneity of the mammalian SWI-SNF complex. EMBO J (1996) 6.36
Diversity and specialization of mammalian SWI/SNF complexes. Genes Dev (1996) 6.01
Human Smad3 and Smad4 are sequence-specific transcription activators. Mol Cell (1998) 5.88
Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2. Nat Med (1999) 5.50
Complete genome sequence and comparative genomics of Shigella flexneri serotype 2a strain 2457T. Infect Immun (2003) 5.11
SOX9 directly regulates the type-II collagen gene. Nat Genet (1997) 4.88
Arsenic poisoning of Bangladesh groundwater. Nature (1998) 4.09
Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene. Proc Natl Acad Sci U S A (1996) 3.88
Composite co-activator ARC mediates chromatin-directed transcriptional activation. Nature (1999) 3.32
Loss of P-glycoprotein expression in hematopoietic stem cells does not improve responses to imatinib in a murine model of chronic myelogenous leukemia. Leukemia (2005) 3.13
CIR, a corepressor linking the DNA binding factor CBF1 to the histone deacetylase complex. Proc Natl Acad Sci U S A (1999) 2.81
Identification of functionally variant MDR1 alleles among European Americans and African Americans. Clin Pharmacol Ther (2001) 2.79
A specificity and targeting subunit of a human SWI/SNF family-related chromatin-remodeling complex. Mol Cell Biol (2000) 2.70
Critical role for alpha/beta and gamma interferons in persistence of lymphocytic choriomeningitis virus by clonal exhaustion of cytotoxic T cells. J Virol (2001) 2.69
The transcriptional cofactor complex CRSP is required for activity of the enhancer-binding protein Sp1. Nature (1999) 2.61
Conservation. Reconsidering the consequences of selective fisheries. Science (2012) 2.57
High AAV vector purity results in serotype- and tissue-independent enhancement of transduction efficiency. Gene Ther (2009) 2.54
The Ski oncoprotein interacts with the Smad proteins to repress TGFbeta signaling. Genes Dev (1999) 2.52
RNA- and DNA-binding activities in hepatitis B virus capsid protein: a model for their roles in viral replication. J Virol (1992) 2.42
Architectural DNA binding by a high-mobility-group/kinesin-like subunit in mammalian SWI/SNF-related complexes. Proc Natl Acad Sci U S A (1998) 2.30
The chromo superfamily: new members, duplication of the chromo domain and possible role in delivering transcription regulators to chromatin. Nucleic Acids Res (1995) 2.26
Microsurgical replantation of the avulsed scalp: report of 20 cases. Plast Reconstr Surg (1996) 2.17
DNA array studies demonstrate convergent regulation of virulence factors by Cph1, Cph2, and Efg1 in Candida albicans. J Biol Chem (2001) 2.14
Abeta amyloid fibrils possess a core structure highly resistant to hydrogen exchange. Proc Natl Acad Sci U S A (2000) 2.02
Reconstitution of transcription factor SL1: exclusive binding of TBP by SL1 or TFIID subunits. Science (1994) 1.98
Human TAFII 105 is a cell type-specific TFIID subunit related to hTAFII130. Cell (1996) 1.96
Dopamine D1 receptor-dependent trafficking of striatal NMDA glutamate receptors to the postsynaptic membrane. J Neurosci (2001) 1.94
Atriopeptins as cardiac hormones. Hypertension (1985) 1.91
TATA box-binding protein (TBP)-related factor 2 (TRF2), a third member of the TBP family. Proc Natl Acad Sci U S A (1999) 1.86
The majority of N-methyl-D-aspartate receptor complexes in adult rat cerebral cortex contain at least three different subunits (NR1/NR2A/NR2B). Mol Pharmacol (1997) 1.81
Transient immunosuppression allows transgene expression following readministration of adeno-associated viral vectors. Hum Gene Ther (1998) 1.79
SREBP transcriptional activity is mediated through an interaction with the CREB-binding protein. Genes Dev (1996) 1.76
The dopamine D3 receptor: a therapeutic target for the treatment of neuropsychiatric disorders. CNS Neurol Disord Drug Targets (2006) 1.74
Enteric bacterial catalysts for fuel ethanol production. Biotechnol Prog (1999) 1.74
A human condensin complex containing hCAP-C-hCAP-E and CNAP1, a homolog of Xenopus XCAP-D2, colocalizes with phosphorylated histone H3 during the early stage of mitotic chromosome condensation. Mol Cell Biol (2000) 1.73
VirB1, a component of the T-complex transfer machinery of Agrobacterium tumefaciens, is processed to a C-terminal secreted product, VirB1. J Bacteriol (1997) 1.72
Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease. J Neurosci (2001) 1.72
Identification of two distinct human SMC protein complexes involved in mitotic chromosome dynamics. Proc Natl Acad Sci U S A (1998) 1.68
Metabotropic glutamate receptor mRNA expression in the basal ganglia of the rat. J Neurosci (1994) 1.67
Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neuroscience (1989) 1.64
Exogenously regulated stem cell-mediated gene therapy for bone regeneration. Mol Ther (2001) 1.63
Lesion of the subthalamic nucleus for the alleviation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the primate. Mov Disord (1991) 1.62
A TRF1:BRF complex directs Drosophila RNA polymerase III transcription. Cell (2000) 1.59
Requirement for a kinase-specific chaperone pathway in the production of a Cdk9/cyclin T1 heterodimer responsible for P-TEFb-mediated tat stimulation of HIV-1 transcription. J Biol Chem (2000) 1.59
Adeno-associated virus type 2-mediated gene transfer: role of cellular FKBP52 protein in transgene expression. J Virol (2001) 1.58
Engineering the metabolism of Escherichia coli W3110 for the conversion of sugar to redox-neutral and oxidized products: homoacetate production. Proc Natl Acad Sci U S A (2003) 1.57
Molecular cloning and expression of the 32-kDa subunit of human TFIID reveals interactions with VP16 and TFIIB that mediate transcriptional activation. Proc Natl Acad Sci U S A (1995) 1.57
Pathophysiology of levodopa-induced dyskinesia: potential for new therapies. Nat Rev Neurosci (2001) 1.57
Identification and characterization of a TFIID-like multiprotein complex from Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (1995) 1.56
X-ray crystal structure of rabbit N-acetylglucosaminyltransferase I: catalytic mechanism and a new protein superfamily. EMBO J (2000) 1.56
Efficiency of eight different AAV serotypes in transducing rat myocardium in vivo. Gene Ther (2007) 1.56
A micromolar pool of antigenically distinct precursors is required to initiate cooperative assembly of hepatitis B virus capsids in Xenopus oocytes. J Virol (1993) 1.55
Abnormal compartmentalization of cartilage matrix components in mice lacking collagen X: implications for function. J Cell Biol (1997) 1.55
The basic helix-loop-helix transcription factor Cph2 regulates hyphal development in Candida albicans partly via TEC1. Mol Cell Biol (2001) 1.52
Post-transcriptional modification in archaeal tRNAs: identities and phylogenetic relations of nucleotides from mesophilic and hyperthermophilic Methanococcales. Nucleic Acids Res (2001) 1.52
Systematic review of chimney and periscope grafts for endovascular aneurysm repair. Br J Surg (2013) 1.50
Ventricular atriopeptin. Unmasking of messenger RNA and peptide synthesis by hypertrophy or dexamethasone. Hypertension (1987) 1.49
The Escherichia coli GTPase CgtAE cofractionates with the 50S ribosomal subunit and interacts with SpoT, a ppGpp synthetase/hydrolase. J Bacteriol (2004) 1.48
Nerve sprouting and sympathetic hyperinnervation in a canine model of atrial fibrillation produced by prolonged right atrial pacing. Circulation (2001) 1.45
Migration of As, and (3)H/(3)He ages, in groundwater from West Bengal: Implications for monitoring. Water Res (2010) 1.45
Source localisation of 62-electrode human laser pain evoked potential data using a realistic head model. Int J Psychophysiol (2001) 1.39
A gross and microscopic study of cerebral injuries accompanying maxillofacial high-velocity projectile wounding in dogs. J Oral Maxillofac Surg (1998) 1.39
Enforced P-glycoprotein pump function in murine bone marrow cells results in expansion of side population stem cells in vitro and repopulating cells in vivo. Blood (2000) 1.39
A comparative study of the skeletal morphology of the temporo-mandibular joint of children and adults. J Postgrad Med (2008) 1.39
Fuzzy control system design via fuzzy Lyapunov functions. IEEE Trans Syst Man Cybern B Cybern (2008) 1.38
An integrated assessment model of carbon sequestration benefits: a case study of Liping county, China. J Environ Manage (2006) 1.38
Problems associated with iontophoretic studies in the caudate nucleus and substantia nigra. Neuropharmacology (1974) 1.37
Five unique compounds: xyloketals from mangrove fungus Xylaria sp. from the South China Sea coast. J Org Chem (2001) 1.37
Association of AMPA receptors with a subset of glutamate receptor-interacting protein in vivo. J Neurosci (1999) 1.37
NMDA receptor subunit mRNA expression by projection neurons and interneurons in rat striatum. J Neurosci (1995) 1.37
Gene expression profiling in the post-mortem human brain--no cause for dismay. J Chem Neuroanat (2001) 1.36
Changes in the use of radiotherapy in Ontario 1984-1995. Int J Radiat Oncol Biol Phys (1999) 1.36
Protection and in vivo selection of hematopoietic stem cells using temozolomide, O6-benzylguanine, and an alkyltransferase-expressing retroviral vector. Mol Ther (2001) 1.33
Series "matrix metalloproteinases in lung health and disease": Matrix metalloproteinases in COPD. Eur Respir J (2011) 1.33
Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease. FASEB J (2000) 1.32
The Epstein-Barr virus lytic transactivator Zta interacts with the helicase-primase replication proteins. J Virol (1998) 1.31
Molecular cloning and characterization of dTAFII30 alpha and dTAFII30 beta: two small subunits of Drosophila TFIID. Genes Dev (1993) 1.30
Engineered human mesenchymal stem cells: a novel platform for skeletal cell mediated gene therapy. J Gene Med (2001) 1.30
Axonal transport of adeno-associated viral vectors is serotype-dependent. Gene Ther (2012) 1.29
Atriopeptin-immunoreactive neurons in the brain: presence in cardiovascular regulatory areas. Science (1985) 1.29
N-methyl-D-aspartate-induced excitation and sensitization of normal and inflamed nociceptors. Neuroscience (2003) 1.27
Comparison of eight clinical rating scales used for the assessment of MPTP-induced parkinsonism in the Macaque monkey. J Neurosci Methods (2000) 1.27
Genetic immunization with adeno-associated virus vectors expressing herpes simplex virus type 2 glycoproteins B and D. J Virol (1997) 1.27
Variation in health and risk behavior among youth living with HIV. AIDS Educ Prev (2001) 1.26
Prophylactic immune tolerance induced by changing the ratio of antigen-specific effector to regulatory T cells. J Thromb Haemost (2009) 1.26
Altered responses to dopaminergic D2 receptor activation and N-type calcium currents in striatal cholinergic interneurons in a mouse model of DYT1 dystonia. Neurobiol Dis (2006) 1.25
Factors affecting the use of palliative radiotherapy in Ontario. J Clin Oncol (2001) 1.25
Immunohistochemical localization of metabotropic glutamate receptors mGluR1a and mGluR2/3 in the rat basal ganglia. J Comp Neurol (1998) 1.24
Differential neuroprotective effects of 14-3-3 proteins in models of Parkinson's disease. Cell Death Dis (2010) 1.23
Spinal and trigeminal dorsal horn projections to the parabrachial nucleus in the rat. J Comp Neurol (1985) 1.23